SYRS Syros Pharmaceuticals: Quarterly Revenue Growth

SYRS (Syros Pharmaceuticals) - company brandmark

Syros Pharmaceuticals (SYRS) is currently undergoing a rigorous debt restructuring process and seeking buyers for its patents. The operating model is based on the full outsourcing of clinical phases to third-party contractors. Quarterly revenue changes on the GURU.Markets terminal chart confirm this decline, with the metric holding around 0.00, highlighting the company's focus on the development of tamibarotene for leukemia therapy.

SYRS (Syros Pharmaceuticals Inc.) Quarterly Sales Growth history from 07/04/2022 to 03/29/2025

Summary analytical data breakdowns for Syros (SYRS)

- current quotes and average value forecast:
- cash and cash flow statistics:
Summary company analytics:syros.com (SYRS)
Flagship merchandise of Syros Pharmaceuticals Inc.

For Syros Pharmaceuticals (SYRS), which is developing targeted leukemia therapies, quarterly revenue growth statistics serve as an indicator of drug commercialization during the clinical trial stage. This metric measures the percentage change in revenue between the current and previous quarter, allowing investors to use the chart's price action to identify a hidden slowdown in cash flows before it becomes evident in annual reports.

Competitors of Syros Pharmaceuticals

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Quarterly Revenue Growth ultragenyx.com (RARE)|Quarterly Revenue Growth BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Quarterly Revenue Growth Rate|twistbioscience.com - Quarterly Revenue Growth|10x Genomics, Inc. - Sales Change QoQ|NTLA (Intellia Corp) - Quarterly Sales Growth|Quarterly Sales Growth stoketherapeutics.com|Quarterly Sales Growth BLFS|Quarterly Sales Growth Wave Life Sciences Corp (WVE)|Quarterly Revenue Growth MAZE|Quarterly Sales Growth Rate Sionna Therapeutics Inc|Revenue Growth QoQ Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Quarterly Revenue Growth Rate|QURE - Revenue Growth QoQ|MeiraGTx Holdings (MGTX) - Quarterly Sales Growth|Regenxbio (RGNX) - Revenue Growth QoQ|SLDB - Quarterly Sales Growth Rate|OCGN (Ocugen Inc) - Quarterly Revenue Growth|Revenue Growth QoQ PACB|Revenue Growth QoQ Benitec (BNTC)|Design Therapeutics Inc - Sales Growth QoQ|Revenue Growth QoQ Rocket Pharma RCKT|Quarterly Revenue Growth 4DMT FDMT|LXEO - Revenue Growth QoQ|Quarterly Revenue Growth Rate Korro Bio Inc.|EDIT: Quarterly Revenue Growth|SLN - Quarterly Sales Growth Rate|PRQR (ProQR Therapeutics) - Quarterly Revenue Growth|codexis.com (CDXS) - Quarterly Sales Growth Rate|Quarterly Revenue Growth SGMO|Quarterly Revenue Growth Nautilus Biotechnology, Inc. (NAUT)|Quarterly Revenue Growth MGX (Metagenomi Inc.)|Quarterly Revenue Increase DTIL|Generation Bio Co. - Quarterly Revenue Growth|BOLD: Revenue Growth QoQ|XCUR (Exicure, Inc.) - Quarterly Sales Growth|Sales Growth QoQ IMNN|Revenue Growth QoQ RXi Pharmaceuticals|mustangbio.com (MBIO) - Quarterly Sales Growth Rate|Revenue Growth QoQ TransCode (RNAZ)|Bionano Genomics Inc. - Sales Growth QoQ|Applied DNA Sciences - Quarterly Sales Growth|Quarterly Sales Growth Rate bluebirdbio.com (BLUE)|IPA - Revenue Growth QoQ|OMGA - Quarterly Revenue Growth|OMIC (Singular Genomics Systems, Inc.) - Quarterly Sales Growth|Regulus Therapeutics Inc - Quarterly Revenue Increase|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)